Teriflunomide Tablet, Film Coated
Product Images NDC 46708-313

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Teriflunomide (NDC 46708-313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

28 Tablets (Teriflunomide Carton 14mg)

This is a description of Teriflunomide Tablets, with each tablet containing 14 mg of teriflunomide. The tablets can be taken with or without food, and should be kept out of the reach of children. They should be stored at a temperature not above 30°C (86°F). The medication guide should be dispensed to each patient by the pharmacist. The tablets are manufactured by Alembic Pharmaceuticals Limited in Gujarat, India. There are two packages available, each containing 28 tablets, and the product is only available with a prescription.*

FDA Label Image

28 Tablets (Teriflunomide Carton 7mg)

Teriflunomide Tablets is a medication produced by Alembic Pharmaceuticals Limited. The tablets contain 7mg of teriflunomide and are typically taken orally once a day with or without food. They are available in packages of 28 tablets and are to be kept out of reach of children. It is recommended to include a medication guide when dispensing the tablets to patients. The tablets should be stored at controlled room temperature, between 15°C to 30°C.*

FDA Label Image

Fig2 (Teriflunomide Fig2)

This text seems to be a table of values showing the results of a clinical trial comparing two different dosage strengths of Terifunomide tablets (7mg and 14 mg) against a Placebo, where the percentages of participants experiencing a certain outcome are reported. The values are recorded at different time intervals ranging from 0 to 36 months. The text also shows the Number at Risk for each group at different time points. Overall, it appears to be a study evaluating the efficacy of Terifunomide Tablets at different dosage strengths.*

FDA Label Image

Figure 1 (Teriflunomide Fige1)

FDA Label Image

Structure (Teriflunomide Structure)

FDA Label Image

28 Tablets (Teriflunomide Wallet 14mg)

Teriflunomide Tablets are for prescription use only and are available in 14mg strength with 28 tablets in each package. The medication guide should be dispensed with each prescription to patients. The package has opening instructions, and the manufacturer information is from Aentic Pharma Limited, located in Panchmaha, Gujarat, India. Some of the text is not readable.*

FDA Label Image

28 Tablets (Teriflunomide Wallet 7mg)

Teriflunomide Tablets are available in a bottle of 28 tablets each with NDC 46708-313-14. The pharmacy should dispense the accompanying medication guide to every patient. The tablet strength is 7mg per tablet. The opening instructions are not available due to unclear text obtained by .*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.